Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
(NASDAQ: CMPS) Delayed: 15.00 +1.20 (8.70%)
Previous Close $13.80    52 Week High $ 
Open $14.06    52 Week Low $ 
Day High $15.41    P/E N/A 
Day Low $14.00    EPS $ 
Volume 4,967,784